Theravance Biopharma

TBPHNasdaq Cayman Islands Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$885.215 M

$17.05 +0.18%

Close of 21 Sept 2026

Revenue

$107.5M

#2480 by revenue

Earnings

$105.9M

#1286 by earnings

Shares outstanding

51,918,754

Latest filing cover page

P/E ratio

8.4

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#162CryoportCYRX$892.4M
#163Immix BiopharmaIMMX$892.1M
#164Theravance BiopharmaTBPH$885.2M
#165Rigel PharmaceuticalsRIGL$879.6M
#166ArdelyxARDX$872.2M

What if Theravance Biopharma were worth as much as…

Open the what-if tool →

Gold $30.3T

$583,104.40

Per share 34,200× higher

Bitcoin $1.72T

$33,124.90

Per share 1,943× higher

Nvidia $5.48T

$105,546.79

Per share 6,190× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for Theravance Biopharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.